EPAS1 trans-Activation during Hypoxia Requires p42/p44 MAPK

• Published in: The Journal of biological chemistry Vol. 274; no. 47; pp. 33709 - 33713
• Main Authors: Conrad, P. William, Freeman, Thomas L., Beitner-Johnson, Dana, Millhorn, David E.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 19-11-1999; American Society for Biochemistry and Molecular Biology
• Subjects: Animals; Basic Helix-Loop-Helix Transcription Factors; Cell Hypoxia; EPAS1 protein; Gene Expression Regulation; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases - metabolism; p42 protein; p44 protein; PC12 Cells; PD98059; Phosphorylation; Ras protein; Rats; Trans-Activators - genetics; Transcriptional Activation
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.274.47.33709

Hypoxia is a common environmental stress that regulates gene expression and cell function. A number of hypoxia-regulated transcription factors have been identified and have been shown to play critical roles in mediating cellular responses to hypoxia. One of these is the endothelial PAS-domain protein 1 (EPAS1/HIF2-α/HLF/HRF). This protein is 48% homologous to hypoxia-inducible factor 1-α (HIF1-α). To date, virtually nothing is known about the signaling pathways that lead to either EPAS1 or HIF1-α activation. Here we show that EPAS1 is phosphorylated when PC12 cells are exposed to hypoxia and that p42/p44 MAPK is a critical mediator of EPAS1 activation. Pretreatment of PC12 cells with the MEK inhibitor, PD98059, completely blocked hypoxia-inducedtrans-activation of a hypoxia response element (HRE) reporter gene by transfected EPAS1. Likewise, expression of a constitutively active MEK1 mimicked the effects of hypoxia on HRE reporter gene expression. However, pretreatment with PD98059 had no effect on EPAS1 phosphorylation during hypoxia, suggesting that MAPK targets other proteins that are critical for thetrans-activation of EPAS1. We further show that hypoxia-induced trans-activation of EPAS1 is independent of Ras. Finally, pretreatment with calmodulin antagonists nearly completely blocked both the hypoxia-induced phosphorylation of MAPK and the EPAS1 trans-activation of HRE-Luc. These results demonstrate that the MAPK pathway is a critical mediator of EPAS1 activation and that activation of MAPK and EPAS1 occurs through a calmodulin-sensitive pathway and not through the GTPase, Ras. These results are the first to identify a specific signaling pathway involved in EPAS1 activation.